MBX Biosciences, Inc. (MBX)
53.49
+0.39
(+0.73%)
USD |
NASDAQ |
Nov 18, 16:00
54.20
+0.71
(+1.33%)
After-Hours: 20:00
MBX Biosciences Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 83.68% |
| Xeris Biopharma Holdings, Inc. | 85.88% |
| ANI Pharmaceuticals, Inc. | 54.92% |
| Corcept Therapeutics, Inc. | 98.65% |
| Veru, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.93% |
| Return on Assets | -33.36% |
| Return on Invested Capital | -34.79% |
| Return on Net Operating Assets | -1.52K% |